| Product Code: ETC7648024 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Industry Life Cycle |
3.4 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Porter's Five Forces |
3.5 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic obstructive pulmonary disease (COPD) in Israel |
4.2.2 Rising geriatric population in Israel |
4.2.3 Technological advancements in COPD treatment options |
4.2.4 Government initiatives to improve respiratory healthcare services in Israel |
4.3 Market Restraints |
4.3.1 High cost associated with COPD treatment and medications |
4.3.2 Limited access to advanced COPD treatment in certain regions of Israel |
4.3.3 Stringent regulatory requirements for approval of COPD treatment drugs |
4.3.4 Lack of awareness about COPD symptoms and treatment options among the population |
5 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends |
6 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Types |
6.1 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Combination Therapy, 2021- 2031F |
6.1.4 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Bronchodilators, 2021- 2031F |
6.1.5 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.6 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Phosphodiesterase Type 4 Inhibitor, 2021- 2031F |
6.1.7 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Mucokinetics, 2021- 2031F |
6.1.8 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Chronic Bronchitis, 2021- 2031F |
6.2.3 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Emphysema, 2021- 2031F |
6.3 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Import-Export Trade Statistics |
7.1 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Export to Major Countries |
7.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Imports from Major Countries |
8 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Key Performance Indicators |
8.1 Average number of COPD patients diagnosed annually |
8.2 Adoption rate of new COPD treatment technologies in Israel |
8.3 Rate of hospital readmissions for COPD-related complications |
8.4 Percentage of COPD patients receiving regular follow-up care |
8.5 Average time taken for COPD patients to receive treatment after diagnosis |
9 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Opportunity Assessment |
9.1 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Competitive Landscape |
10.1 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here